Quiz|Articles|September 7, 2025
Dermatology Times Spot Test: September 7, 2025
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- Chronic hand eczema involves inflammation, itching, and skin barrier dysfunction, often worsened by environmental and occupational factors.
- Advancements in CHE understanding have improved diagnostic criteria and treatment options, including topical and systemic therapies.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology.
This week, we'll focus on the latest news in
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
What is the estimated annual societal cost per patient with CHE in Europe, according to this recent review?
What percentage of CHE patients reportedly prefer non-steroidal treatments over topical corticosteroids?
Which additional potential indication for delgocitinib is being assessed in future research, according to Robert Spurr, executive vice president, North America, LEO Pharma?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
